Boehringer Ingelheim Pharms., Inc. v. Dep't of Health & Hum. Servs.
Court Reverses HHS Decision on 340B Program Exclusion
ca2 · 2025-08-07 · Reversed · Impact: 65/100
Boehringer Ingelheim Pharms., Inc. v. Dep't of Health & Hum. Servs., decided by Second Circuit on August 7, 2025, resulted in a reversed outcome. The Second Circuit reviewed the Department of Health a...